Taylor Wealth Management Partners’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Taylor Wealth Management Partners’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$14K	Sell	10,700 -935	-8%	-$1.6K	0.01%	54
2022 Q1	$28K	Hold	11,635	–	–	0.01%	63
2021 Q4	$53K	Sell	11,635 -46,377	-80%	-$153K	0.02%	62
2021 Q3	$470K	Sell	58,012 -7,180	-11%	-$61.5K	0.17%	53
2021 Q2	$641K	Buy	65,192 +210	+0.3%	+$1.71K	0.23%	49
2021 Q1	$573K	Buy	64,982 +229	+0.4%	+$2.51K	0.21%	55
2020 Q4	$662K	Buy	64,753 +2,582	+4%	+$28.2K	0.25%	49
2020 Q3	$562K	Buy	62,171 +2,241	+4%	+$17.8K	0.26%	44
2020 Q2	$428K	Buy	+59,930	New	+$636K	0.22%	40

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Taylor Wealth Management Partners's GRTX Position: Q2 2022 in Review

Taylor Wealth Management Partners reduced its Galera Therapeutics, Inc. Common Stock (GRTX) stake by 8% in Q2 2022, selling an estimated $1.6K and leaving 10,700 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #54.

Taylor Wealth Management Partners first reported a position in GRTX in Q2 2020 and has held it in 9 quarters since. The position peaked at $662K in Q4 2020. 39 funds tracked by Wall St. Rank hold GRTX as of Q2 2022.

Taylor Wealth Management Partners held 10,700 shares of Galera Therapeutics, Inc. Common Stock worth $14K as of Q2 2022.
Taylor Wealth Management Partners sold 935 Galera Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $1.6K.
Galera Therapeutics, Inc. Common Stock made up 0.01% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #54 holding.
Taylor Wealth Management Partners first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2020 and has held it in 9 quarters since.
Taylor Wealth Management Partners's Galera Therapeutics, Inc. Common Stock position peaked at $662K in Q4 2020.
39 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.